| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/JCP.0B013E31823F872F |
| P698 | PubMed publication ID | 22198448 |
| P50 | author | Joseph R Calabrese | Q90776679 |
| P2093 | author name string | Jun Zhao | |
| Mary Mackle | |||
| Armin Szegedi | |||
| John Panagides | |||
| Apollo Study Group | |||
| Let Stet | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bipolar disorder | Q131755 |
| asenapine | Q416545 | ||
| P304 | page(s) | 46-55 | |
| P577 | publication date | 2012-02-01 | |
| P1433 | published in | Journal of Clinical Psychopharmacology | Q6294969 |
| P1476 | title | Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension | |
| P478 | volume | 32 |
| Q47724110 | A Review of Asenapine in the Treatment of Bipolar Disorder |
| Q30353864 | A review of the pharmacology, efficacy and tolerability of recently approved and upcoming oral antipsychotics: an evidence-based medicine approach. |
| Q36868401 | Asenapine augmentation in bipolar disorders: a case series |
| Q26775399 | Asenapine for bipolar disorder |
| Q38077281 | Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice |
| Q36515504 | Asenapine in bipolar I disorder: evidence and place in patient management |
| Q36794665 | Asenapine in the treatment of older adults with bipolar disorder |
| Q38209103 | Asenapine review, part I: chemistry, receptor affinity profile, pharmacokinetics and metabolism |
| Q38209081 | Asenapine review, part II: clinical efficacy, safety and tolerability |
| Q34308027 | Combination therapy for manic phases: a critical review of a common practice |
| Q41973696 | Comparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorder |
| Q89665749 | Complex Combination Pharmacotherapy for Bipolar Disorder: Knowing When Less Is More or More Is Better |
| Q34100578 | Cost-effectiveness of asenapine in the treatment of patients with bipolar I disorder with mixed episodes in an Italian context |
| Q37649909 | Does the efficacy of asenapine in bipolar disorder increase in the presence of comorbidity with a substance use disorder? A naturalistic study |
| Q47661666 | Efficacy and Tolerability of Asenapine Compared with Olanzapine in Borderline Personality Disorder: An Open-Label Randomized Controlled Trial |
| Q38012647 | Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry |
| Q34114890 | Everolimus and intensive behavioral therapy in an adolescent with tuberous sclerosis complex and severe behavior |
| Q36568973 | How assess drugs in the treatment of acute bipolar mania? |
| Q34641024 | Iloperidone, asenapine and lurasidone: a primer on their current status |
| Q34474219 | Lithium as add-on to quetiapine XR in adult patients with acute mania: a 6-week, multicenter, double-blind, randomized, placebo-controlled study |
| Q38243695 | Mood stabilizers and antipsychotics for acute mania: a systematic review and meta-analysis of combination/augmentation therapy versus monotherapy. |
| Q36929705 | New approaches for the management of bipolar disorder: role of sublingual asenapine in the treatment of mania |
| Q38085441 | Oral antipsychotic update: a brief review of new and investigational agents for the treatment of schizophrenia |
| Q38364834 | Pharmacotherapy of acute mania: monotherapy or combination therapy with mood stabilizers and antipsychotics? |
| Q38536939 | Safety and tolerability of antipsychotic-mood stabilizer co-treatment in the management of acute bipolar disorder: results from a systematic review and exploratory meta-analysis |
| Q28066714 | The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm |
| Q34649187 | The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder |
| Q38057380 | The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar mania. |
| Q38236045 | Use of asenapine as add-on therapy in the treatment of bipolar disorder: a comprehensive review and case series |
| Q38093728 | Use of asenapine in clinical practice for the management of bipolar mania |
Search more.